Publications by authors named "Wim Bleeker"

Claim this Profile
L
LekCheck: A Prospective Study to Identify Perioperative Modifiable Risk Factors for Anastomotic Leakage in Colorectal Surgery.
Daitlin E Huisman, Muriël Reudink, Stefanus J van Rooijen, Boukje T Bootsma, Tim van de Brug, Wim Bleeker

Ann Surg· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ergonomics in handheld and robot-assisted camera control: a randomized controlled trial.
Paul J M Wijsman, Lennert Molenaar, Cas D P Van't Hullenaar, Bas S T van Vugt, Wim A Bleeker

Surg Endosc· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Acute abdominal pain caused by neuroborreliosis].
Anna S M Dobbe, Aleksandra C Zoethout, Wim A Bleeker, Dettie G Oenema

Ned Tijdschr Geneeskd· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma.
Marije B Overdijk, Sandra Verploegen, Marijn Bögels, Marjolein van Egmond, Jeroen J Lammerts van Bueren, Wim K Bleeker

MAbs· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High turnover of tissue factor enables efficient intracellular delivery of antibody-drug conjugates.
Bart E C G de Goeij, David Satijn, Claudia M Freitag, Richard Wubbolts, Wim K Bleeker

Mol Cancer Ther· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 monoclonal antibodies that do not interfere with receptor heterodimerization-mediated signaling induce effective internalization and represent valuable components for rational antibody-drug conjugate design.
Bart E C G de Goeij, Matthias Peipp, Simone de Haij, Edward N van den Brink, Christian Kellner, Wim K Bleeker

MAbs· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-dimensional histologic validation of high-resolution SPECT of antibody distributions within xenografts.
Woutjan Branderhorst, Erwin L A Blezer, Mischa Houtkamp, Ruud M Ramakers, Jeroen H van den Brakel, Wim K Bleeker

J Nucl Med· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An antibody-drug conjugate that targets tissue factor exhibits potent therapeutic activity against a broad range of solid tumors.
Esther C W Breij, Bart E C G de Goeij, Sandra Verploegen, Danita H Schuurhuis, Ali Amirkhosravi, Wim K Bleeker

Cancer Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgA EGFR antibodies mediate tumour killing in vivo.
Peter Boross, Stefan Lohse, Maaike Nederend, Johannes Hendrik Marco Jansen, Geert van Tetering, Wim K Bleeker

EMBO Mol Med· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crosstalk between human IgG isotypes and murine effector cells.
Marije B Overdijk, Sandra Verploegen, Antonio Ortiz Buijsse, Tom Vink, Jeanette H W Leusen, Wim K Bleeker

J Immunol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction for Lammerts van Bueren et al. The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.
Jeroen J Lammerts van Bueren, Wim K Bleeker, Annika Brännström, Magnus Jansson, Matthias Peipp

Proc Natl Acad Sci U S A· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-cell depletion attenuates white and gray matter pathology in marmoset experimental autoimmune encephalomyelitis.
Yolanda S Kap, Jan Bauer, Nikki van Driel, Wim K Bleeker, Paul W H I Parren

J Neuropathol Exp Neurol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor (EGFR) antibody-induced antibody-dependent cellular cytotoxicity plays a prominent role in inhibiting tumorigenesis, even of tumor cells insensitive to EGFR signaling inhibition.
Marije B Overdijk, Sandra Verploegen, Jeroen H van den Brakel, Jeroen J Lammerts van Bueren, Tom Vink, Wim K Bleeker

J Immunol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted multi-pinhole SPECT.
Woutjan Branderhorst, Brendan Vastenhouw, Frans van der Have, Erwin L A Blezer, Wim K Bleeker

Eur J Nucl Med Mol Imaging· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.
Michel de Weers, Yu-Tzu Tai, Michael S van der Veer, Joost M Bakker, Tom Vink, Wim K Bleeker

J Immunol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late B cell depletion with a human anti-human CD20 IgG1κ monoclonal antibody halts the development of experimental autoimmune encephalomyelitis in marmosets.
Yolanda S Kap, Nikki van Driel, Erwin Blezer, Paul W H I Parren, Wim K Bleeker

J Immunol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human IgG2 antibodies against epidermal growth factor receptor effectively trigger antibody-dependent cellular cytotoxicity but, in contrast to IgG1, only by cells of myeloid lineage.
Tanja Schneider-Merck, Jeroen J Lammerts van Bueren, Sven Berger, Kai Rossen, Patrick H C van Berkel, Wim K Bleeker

J Immunol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques.
Ann J Hessell, Pascal Poignard, Meredith Hunter, Lars Hangartner, David M Tehrani, Wim K Bleeker

Nat Med· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo.
Aran F Labrijn, Antonio Ortiz Buijsse, Ewald T J van den Bremer, Annemiek Y W Verwilligen, Wim K Bleeker

Nat Biotechnol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells.
Matthias Peipp, Jeroen J Lammerts van Bueren, Tanja Schneider-Merck, Wim W K Bleeker, Michael Dechant

Blood· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement-dependent tumor cell lysis triggered by combinations of epidermal growth factor receptor antibodies.
Michael Dechant, Wencke Weisner, Sven Berger, Matthias Peipp, Thomas Beyer, Wim K Bleeker

Cancer Res· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.
Jeroen J Lammerts van Bueren, Wim K Bleeker, Annika Brännström, Anne von Euler, Magnus Jansson

Proc Natl Acad Sci U S A· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor cell killing mechanisms of epidermal growth factor receptor (EGFR) antibodies are not affected by lung cancer-associated EGFR kinase mutations.
Matthias Peipp, Tanja Schneider-Merck, Michael Dechant, Thomas Beyer, Jeroen J Lammerts van Bueren, Wim K Bleeker

J Immunol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of dose requirements for sustained in vivo activity of a therapeutic human anti-CD20 antibody.
Wim K Bleeker, Martin E Munk, Wendy J M Mackus, Jeroen H N van den Brakel, Marielle Pluyter

Br J Haematol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange.
Marijn van der Neut Kolfschoten, Janine Schuurman, Mario Losen, Wim K Bleeker, Pilar Martínez-Martínez

Science· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis